Analysis of the genes for oestrogen and epidermal growth factor receptors in human breast cancer

Breast

Volumn 5, Issue 5, 1996, Pages 344-350

  Sharma, A K ^a,c   Grimshaw, D ^a   Horgan, K ^a   Neades, G T ^a   Gee, J M W ^b   Douglas Jones, A G ^b   Mansel, R E ^a   Nicholson, R I ^b  

^a University College of Medicine of Wales   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c Department of Child Dental Health   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; RESTRICTION ENDONUCLEASE;

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTHERN BLOTTING;

EID: 0029994204     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(96)90002-8     Document Type: Article

References (39)

1. Petkovich M, Brand N J, Krust A, Chambon P. A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987; 330: 444-450.
2. Kvinnsland S. Steroid receptor assay and prognosis. In: Stoll B A, ed. Breast Cancer Treatment and Prognosis. Oxford: Blackwell Scientific Publications, 1986, 140-154.
3. McGuire W L, Chamness G C, Fuqua S A W. Abnormal estrogen receptor in clinical breast cancer. J Steroid Biochem Mol Biol 1992; 43: 243-247.
4. Lippman M E, Dickson R B. Mechanisms of growth control in normal and malignant breast epithelium. Recent Prog Horm Res 1989; 45: 383-440.
5. Cohen S, Ushiro H, Stoscheck C, Chinkers M. A native 170 000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles. J Biochem 1982; 257: 1523-1531.
6. Downward J, Parker P, Waterfield M D. Autophosphorylation sites on the epidermal growth factor receptor. Nature 1984; 311: 483-485.
7. Klijn J G M, Berns P M J J, Schmitz P I M, Foekens J A. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr Rev 1992; 13(1): 3-17.
8. Hainsworth P J, Henderson M A, Stillwell R G, Bennett R C. Comparison of EGFR, C-erbB-2 product and ras p21 immunohistochemistry as prognostic markers in primary breast cancer. Eur J Surg Oncol 1991; 17 (1): 9-15.
9. Toi M, Nakamura T, Mukaida H et al. Relationship between epidermal growth factor receptor status and various prognostic factors in human breast cancer. Cancer 1990; 65: 1980-1984.
10. Nicholson S, Wright C, Sainsbury J R C et al. Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in nodenegative breast cancer patients: neu and tamoxifen failure. J Steroid Biochem Mol Biol 1990; 37 (6): 811-814.
11. Lewis S, Locker A, Todd J H et al. Expression of epidermal growth factor receptor in breast carcinoma. J Clin Pathol 1990; 43: 385-389.
12. Sainsbury J R C, Farndon J R, Sherbet G V, Harris A L. Epidermal growth factor receptors and oestrogen receptors in human breast cancer. Lancet 1985; i: 364-366.
13. Watts C K W, Handel M L, King R J B, Sutherland R L. Oestrogen receptor gene structure and function in breast cancer. J Steroid Biochem Mol Biol 1992; 41: 529-536.
14. Koh E H, Ro J, Wildrick D M, Hortobagyi G N, Blick M. Analysis of the estrogen receptor gene structure in human breast cancer. Anticancer Res 1989; 9: 1841-1846.
15. Nembrot M, Quintana B, Mordoh J. Estrogen receptor gene amplification is found in some estrogen receptor-positive human breast tumours. Biochem Biophys Res Commun 1990; 166: 601-607.
16. King C R, Kraus M H, Aaronson S A. Amplification of a novel V-erbB-related gene in a human mammary carcinoma. Science 1985; 299: 974-976.
17. Guérin M, Gabillot M, Mathieu M-C et al. Structure and expression of C-erbB-2 and EGF receptor genes in inflammatory and non-inflammatory breast cancer: prognostic significance. Int J Cancer 1989; 43: 201-208.
18. Lacroix H, Inglehart J D, Skinner M A, Kraus M H. Overexpression of erbB-2 or EGF receptor proteins in early stage mammary carcinoma is detected simultaneously in matched primary tumors and regional metastases. Oncogene 1989; 4: 145-151.
19. Lee J S, Ro J S, Eisbruch A et al. Multiple restriction fragment length polymorphisms of the human epidermal growth factor receptor gene. Cancer Res 1988; 48: 4045-4048.
20. Sharma A K, Horgan K, Douglas-Jones A, McClelland R, Gee J M W, Nicholson R. Dual immunocytochemical analysis of oestrogen and epidermal growth factor receptors in human breast cancer. Br J Cancer 1994; 69: 1032-1037.
21. Sambrook J, Fritsch E F, Maniatis T. In: Nolan C, ed. Molecular Cloning, 2nd end. New York: Cold Spring Harbor Laboratory Press, 1989.
22. Feinberg A P, Vogelstein B. A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983; 132: 6-13.
23. Kumar V, Green S, Staub A, Chambon P. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 1986; 5: 2231-2236.
24. Ullrich A, Coussens L, Hayflick J S et al. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature 1984; 309: 418-425.
25. Khalili K, Salas C, Weinmenn R. Isolation and characterisation of human actin genes cloned in phage lamda vectors. Gene 1983; 21: 9-17.
26. Walter P, Green S, Greene G et al. Cloning of the human estrogen receptor cDNA. Proc Natl Acad Sci USA 1985; 82: 7889-7893.
27. Ponglikitmongkol M, Green S, Chambon P. Genomic organisation of the human oestrogen receptor gene. EMBO J 1988; 7: 3385-3388.
28. Green S, Walter P, Kumar V et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erfc-A. Nature 1986; 320: 134-139.
29. Castagnoli A, Maestri I, Bernardi F, Del Senno L. PvuII RFLP inside the human estrogen receptor gene. Nuc Acids Res 1987; 15: 866.
30. Coleman R T, Taylor J E, Shine J J, Frossard P M. Human estrogen receptor (ESR) gene locus: PssI dimorphism. Nuc Acids Res 1988; 16: 7208.
31. Wanless C, Barker S, Puddefoot J R et al. Somatic change in the estrogen receptor gene associated with altered expression of the progesterone receptor. Anticancer Res 1991; 11: 139-142.
32. Yaich L E, Dupont W D, Cavener D R, Pari F F. The estrogen receptor PvuII restriction fragment length polymorphism is not correlated with estrogen receptor content or patient age in 260 breast cancers. In: The Endocrine Society 1991, p 175 (Abstract), Washington DC.
33. Merlino G T, Ishii S, Whang-Peng J et al. Structure and localisation of genes encoding aberrant and normal epidermal growth factor receptor RNAs from A431 human carcinoma cells. Mol Cell Biol 1985; 5 (7): 1722-1734.
34. Haley J, Whittle N W, Bennett P, Kinchington K, Ullrich A, Waterfield M. The human EGF receptor gene: structure of the 110 kb locus and identification of sequences regulating its transcription. Oncogene Res 1987; 1: 375-396.
35. Lee C S L, Hall R E, Alexander I E, Koga M, Shine J, Sutherland R L. Inverse relationship between estrogen receptor and epidermal growth factor receptor mRNA levels in human breast cancer cell lines. Growth Factors 1990; 3: 97-103.
36. Murphy L C, Murphy L J, Shiu R P C. Progestin regulation of E G F-receptor mRNA accumulation in T-47 human breast cancer cells. Biochem Biophys Res Commun 1988; 150 (1): 192-196.
37. Alexander I E, Shine J, Sutherland R L. Progestin regulation of estrogen receptor messenger RNA in human breast cancer cells. Mol Endocrinol 1990; 4: 821-828.
38. Lee C S L, Koga M, Sutherland R L. Modulation of estrogen receptor and epidermal growth factor receptor mRNAs by phorbol ester in MCF-7 breast cancer cells. Biochem Biophys Res Commun 1989; 163 (1): 415-421.
39. de Fazio A, Chiew Y-E, Donohue C, Lee C S L, Sutherland R L. Effect of sodium butyrate on estrogen receptor and epidermal growth factor receptor gene expression in human breast cancer cell lines. J Biol Chem 1992; 267 (25): 18008-18012.